IBM and Moderna Agree to Work Together Using Generative AI and Quantum Computing Techniques to Help Develop Future mRNA Medicines
dougfinke2023-12-14T17:39:38-08:00Under the arrangement, Moderna will join the IBM Quantum Accelerator program and the IBM Quantum Network and access to IBM's quantum computing systems, along with IBM's expertise in using the technology. In addition, Moderna and IBM's scientist will work together to use IBM's MoLFormer, a pretrained AI model that infers the structure of molecules from simple representations to predict a molecule's physical properties. A key goal for Moderna is to optimize the lipid nanoparticles, which encapsulate and protect the mRNA as it travels within the body and design mRNA medicines with optimal safety and performance.. Additional information about this collaboration is available [...]